Transporting live cells between laboratories without compromising viability is a persistent challenge in research and diagnostics workflows. Temperature fluctuations, mechanical stress, and prolonged transit times can reduce cell recovery, waste resources, and delay projects. Life Science Group manufactures transport media and cell culture reagents specifically developed to address these risks.
This guide walks through seven practical steps for maintaining cell viability during short-term storage and transport. Each step covers a specific handling decision, from medium selection through to post-transit recovery, so you can establish a reliable, repeatable transport protocol in your laboratory.
The medium you choose determines how well cells withstand the stresses of transit. A transport-specific medium should maintain stable pH buffering across a working temperature range, protect cell membranes from mechanical damage, and be free of cytotoxic cryoprotectants such as DMSO.
For mammalian cell lines, look for a transport medium that is xeno-free, chemically defined, and validated for ambient-temperature use. These properties reduce regulatory complexity and eliminate the logistical burden of dry-ice shipments.
Life Science Group produces CellShip®, a defined, xeno-free transport medium validated for up to 120 h of ambient-temperature storage across a range of cell lines. It is manufactured under ISO 13485 and classified as an IVD medical device (UKCA and CE marked).
Cells transported at suboptimal health recover poorly. Before harvesting, confirm that your culture is in logarithmic growth phase and that viability exceeds 90%, as measured by trypan blue exclusion or an automated cell counter.
Check for visible signs of contamination under a light microscope. Inspect medium colour, turbidity, and cell morphology. Contaminated or senescent cultures should not be shipped, as transport stress will compound existing damage.
Target a seeding density appropriate to your cell type. For many mammalian lines, a density of 1 × 10⁶ cells/mL in transport medium provides a reliable starting point, though you should follow the validated protocol for your specific line.
For adherent cells, aspirate spent medium, rinse with DPBS, and add an enzymatic detachment reagent such as trypsin. Incubate at 37℃ until cells detach, then neutralise with complete medium and transfer the suspension to a centrifuge tube.
For suspension cells, transfer the culture directly into a centrifuge tube. Centrifuge at 180–250 × g for 5 min at room temperature. Discard the supernatant and resuspend the pellet in PBS for a single wash step, then centrifuge again.
Minimising the time cells spend outside standard culture conditions during this step reduces handling-induced viability loss.
After the final centrifugation, discard the wash buffer and gently resuspend the pellet in 2–3 mL of your chosen transport medium. Centrifuge once more under the same conditions, then resuspend in the final working volume of transport medium.
Transfer the cell suspension into a sterile, leak-proof vessel. Screw-cap cryotubes (2 mL) work well for smaller volumes, while larger batches may require T-flasks or sealed conical tubes, depending on the validated protocol.
Label each vessel with the cell line name, passage number, cell count, date, and operator initials. Accurate labelling supports traceability through the entire transport and recovery process.
Temperature excursions are a primary cause of reduced post-transport viability. A 2025 study published in CryoLetters found that exposure of cryopreserved cells to −50℃ for three or more days caused measurable decreases in cell recovery across multiple cancer cell lines, highlighting the sensitivity of cells to suboptimal thermal conditions.
For ambient-temperature transport media, use insulated packaging with phase-change materials calibrated to maintain an internal range of approximately 15–25℃. Avoid placing cells directly against cold packs or uninsulated container walls.
If your transport medium supports a wider temperature range (for example, +2℃ to +37℃), you may have more flexibility, but aim to minimise fluctuations regardless. Record the external forecast temperature for the shipping route and adjust insulation accordingly.
Include a calibrated electronic temperature data logger inside each shipment. Position the logger adjacent to, but not touching, the sample vessels. This provides an accurate record of the thermal environment the cells experienced.
Document the following for each shipment: departure time and date, expected transit duration, ambient forecast, courier service and tracking number, and the data logger ID. Retain these records alongside your cell-banking documentation.
Reviewing temperature logs after each shipment helps you identify packaging weaknesses and refine your protocol over time. Consistent documentation also supports compliance with institutional quality management systems.
Upon receipt, gently resuspend cells and transfer them into pre-warmed complete growth medium at the appropriate volume. For transport media that are non-toxic and fully defined, you may not need a separate wash step before seeding.
Seed cells into the appropriate culture vessel and incubate under standard conditions (typically 37℃, 5% CO₂). Observe the culture within 24 h to confirm attachment (for adherent lines) or expected density (for suspension lines).
Record post-transport viability using trypan blue exclusion or an equivalent assay. Comparing pre-shipment and post-receipt viability provides a quantitative measure of your transport protocol's performance and supports iterative optimisation.
Several variables can degrade cell health during transit. Temperature fluctuations outside the validated range of your transport medium are among the most damaging. Mechanical shear from inadequate packaging, contact with cytotoxic preservatives, and prolonged time outside controlled conditions all contribute to membrane damage and apoptosis.
Cell type also plays a role. Primary cells and stem cells tend to be more sensitive to transport stress than established cell lines. A 2025 study in BMC Immunology found that peripheral blood mononuclear cells isolated more than 20 h after blood collection showed reduced NK cell viability and lower antibody-mediated cytotoxicity compared with cells isolated within 6 h (Lehle et al., 2025).
Selecting a transport medium and packaging configuration matched to your specific cell type, transit duration, and expected environmental conditions is the most effective way to control these risks.
Xeno-free media contain no animal- or human-derived proteins, reducing the risk of pathogen transmission and batch-to-batch variability. For laboratories working under IVD regulations or preparing cells for cell therapy applications, this is a practical consideration that can simplify regulatory documentation.
A transport medium manufactured under ISO 13485 and carrying CE or UKCA marking provides an additional layer of assurance. These certifications confirm that the product is manufactured within a documented quality management system and conforms to applicable medical device standards.
Eliminating DMSO from the transport step also removes the need for a post-transport wash before downstream assays. This reduces handling time, lowers the risk of contamination, and means cells can move into culture or analysis faster.
Life Science Group manufactures two transport media at its facility in Sandy, Bedfordshire, under ISO 9001:2015 and ISO 13485:2016 quality systems. CellShip® is a defined, xeno-free cell transport medium validated for up to 120 h of ambient-temperature storage across a range of mammalian cell lines. T-Store® is a chemically defined tissue storage and transportation medium designed to maintain the integrity of mammalian tissue samples.
Both products are DMSO-free, sterile, and manufactured to endotoxin levels conforming to EU standards (≤ 1.0 EU/mL). CellShip® is classified as an IVD medical device, UKCA marked and CE marked, and LSG is ISIA traceability certified.
LSG can customise transport media to suit your exact requirements. Please call us on 01234 889180 or email sales@lifesciencegroup.co.uk to discuss your project.
The duration depends on the medium, cell type, and temperature conditions. Life Science Group's CellShip® is validated for up to 120 h of ambient-temperature transport across multiple mammalian cell lines. Always confirm the validated window for your specific cell type before shipping.
Not necessarily. Ambient-temperature transport media such as CellShip® from Life Science Group eliminate the need for dry ice, reducing logistics costs and avoiding the hazards associated with solid CO₂ handling.
A density of approximately 1 × 10⁶ cells/mL is a common starting point for many mammalian lines, but the validated density varies by cell type and transport medium. Consult the product protocol or contact your supplier for guidance.
Primary cells are often more sensitive to handling and environmental changes than immortalised lines. You may need to optimise transport conditions, density, and duration separately. Life Science Group offers application development support to help validate protocols for specific primary cell types.
Most ambient transport media are formulated for use between approximately +2℃ and +37℃. CellShip® from Life Science Group offers stable pH buffering across this range. Aim to keep the internal package temperature between 15℃ and 25℃ for consistent results, and always use a data logger to verify conditions.